Analyses of the respective expression levels of CD44 and miR-143-3p in human melanocytic nevus and dermal melanoma samples demonstrated medium to high levels of CD44 without correlation with tumor grading or stage. This evidence concerns the gene CD44 and melanocytic nevus.